Nanox New X-ray Machine Could Allow Fast Diagnosis of COVID Pneumonia
Nanox, an Israeli corporation that has developed the first solid state digital X-ray source designed to be used in real-world medical imaging applications, has partnered
BiondVax teams up with Max Planck Society on developing VHH antibodies against COVID-19
BiondVax signed an agreement for a broad-based strategic collaboration with the Max Planck Society (MPG) and University Medical Center Göttingen (UMG), Germany. This 5-year strategic
Jerusalem based Salignostics Launches World’s 1st Saliva Pregnancy Test
Salignostics, an Israeli medical startup, https://www.salignostics.com/ is launching the world’s first pregnancy test that delivers results from saliva samples, the SaliStick, using technology it developed
RenalSense raises $14M Series A Funding to Bolster Global Product Line Commercialization and Expansion
RenalSense™, a leader in real-time renal diagnostics, has secured $14M to bolster the global commercialization of its current product, the Clarity RMS, expand clinical validation
IllumigynTM Raises $33M to Provide Women with Outstanding, Accessible, & Affordable Gynecological Care Worldwide
illumigyn , the world’s first remote gynecological imaging platform, has raised $33M following the closure of its latest investment round. This current investment round includes
Mirror Biologics Issued US Patent Covering Next Gen Therapeutic Vaccine Technology for Cancer & Infectious Disease Treatment
Mirror Biologics, Inc., received a US Patent No. 11,160,852 on the “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of
Oramed’s Oravax Oral COVID-19 Vaccine to Begin Phase 1 Clinical Trial
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed,com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that its majority-owned
Alpha TAU Enrolls Its First Patient in Combination Trial of Alpha DaRT™ & Pembrolizumab (Keytruda)
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, has enrolled its first patient in the combination study of Alpha
Shaare Zedek Scientific Licenses Innovative Neuropsychiatric Cannabinoid Therapy to GCANRx
Shaare Zedek Scientific Ltd., the technology transfer arm of Jerusalem’s Shaare Zedek Medical Center, has entered into a licensing agreement with Greater Cannabis Company, Inc.
